Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1863)
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
3,000
Price
$18.76
Total Value
$56.28K
Shares Held After
3,622
% of Holdings
45.3%
Keros Therapeutics, Inc. (KROS)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$10.58
Total Value
$10.58K
Shares Held After
9,450
% of Holdings
10.6%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
German Christopher Paul — Corporate Controller & CAO
Shares
4,643
Price
$92.21
Total Value
$428.13K
Shares Held After
0
% of Holdings
100.0%
Zai Lab Ltd (ZLAB)
Du Ying — Director
Shares
50,000
Price
$20.74
Total Value
$1.04M
Shares Held After
1,122,626
% of Holdings
4.3%
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
200
Price
$69.12
Total Value
$13.82K
Shares Held After
11,589
% of Holdings
1.7%
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
1,512
Price
$68.23
Total Value
$103.16K
Shares Held After
11,789
% of Holdings
11.4%
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
2,088
Price
$67.53
Total Value
$141.00K
Shares Held After
13,301
% of Holdings
13.6%
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
6,200
Price
$66.69
Total Value
$413.46K
Shares Held After
15,389
% of Holdings
28.7%
Electromed, Inc. (ELMD)
SKARVAN KATHLEEN — Director
Shares
3,562
Price
$37.33
Total Value
$132.97K
Shares Held After
35,622
% of Holdings
9.1%
Electromed, Inc. (ELMD)
SKARVAN KATHLEEN — Director
Shares
9,256
Price
$36.26
Total Value
$335.60K
Shares Held After
39,184
% of Holdings
19.1%
Electromed, Inc. (ELMD)
SKARVAN KATHLEEN — Director
Shares
19,032
Price
$35.24
Total Value
$670.73K
Shares Held After
48,440
% of Holdings
28.2%
Electromed, Inc. (ELMD)
SKARVAN KATHLEEN — Director
Shares
8,150
Price
$34.36
Total Value
$280.06K
Shares Held After
67,472
% of Holdings
10.8%
Pharvaris N.V. (PHVS)
Glassman Robert — Director
Shares
4,667
Price
$29.82
Total Value
$139.15K
Shares Held After
10,500
% of Holdings
30.8%
Pharvaris N.V. (PHVS)
Glassman Robert — Director
Shares
5,333
Price
$29.83
Total Value
$159.09K
Shares Held After
15,167
% of Holdings
26.0%
Pharvaris N.V. (PHVS)
Abele Stefan Andreas — Chief Technical Ops Officer
Shares
8,748
Price
$29.82
Total Value
$260.86K
Shares Held After
35,194
% of Holdings
19.9%
Pharvaris N.V. (PHVS)
Souverijns Wim — Chief Commercial Officer
Shares
10,000
Price
$29.92
Total Value
$299.16K
Shares Held After
45,111
% of Holdings
18.1%
Processa Pharmaceuticals, Inc. (PCSA)
Ng George K — Director
Shares
1,843
Price
$2.97
Total Value
$5.47K
Shares Held After
7,841
% of Holdings
23.5%
Processa Pharmaceuticals, Inc. (PCSA)
Young David — Director
Shares
1,545
Price
$2.97
Total Value
$4.59K
Shares Held After
15,345
% of Holdings
10.1%
Processa Pharmaceuticals, Inc. (PCSA)
Lin Patrick — Chief Business - Strategy Off
Shares
1,369
Price
$2.97
Total Value
$4.07K
Shares Held After
7,594
% of Holdings
18.0%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
456
Price
$72.67
Total Value
$33.14K
Shares Held After
105,212
% of Holdings
0.4%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
2,356
Price
$72.08
Total Value
$169.82K
Shares Held After
105,668
% of Holdings
2.2%
Processa Pharmaceuticals, Inc. (PCSA)
SKIBSTED RUSSELL — Chief Financial Officer
Shares
1,984
Price
$2.97
Total Value
$5.89K
Shares Held After
8,466
% of Holdings
23.4%
Processa Pharmaceuticals, Inc. (PCSA)
Guy Wendy — Chief Administrative Officer
Shares
1,583
Price
$2.97
Total Value
$4.70K
Shares Held After
8,011
% of Holdings
19.8%
Alignment Healthcare, Inc. (ALHC)
Maroney Dawn Christine — President
Shares
30,000
Price
$16.09
Total Value
$482.56K
Shares Held After
998,813
% of Holdings
2.9%
Elanco Animal Health Inc (ELAN)
Modi Rajeev A. — Executive Vice President U.S. Pet Health and Global Digital Transformation
Shares
4,911
Price
$20.35
Total Value
$99.94K
Shares Held After
160,812
% of Holdings
3.1%
DEXCOM INC (DXCM)
Brown Michael Jon — EVP, Chief Legal Officer
Shares
1,700
Price
$59.91
Total Value
$101.85K
Shares Held After
109,504
% of Holdings
1.5%
Elanco Animal Health Inc (ELAN)
Simmons Jeffrey N — Director
Shares
4,971
Price
$20.09
Total Value
$99.84K
Shares Held After
171,971
% of Holdings
2.9%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
1,354
Price
$453.45
Total Value
$613.97K
Shares Held After
24,734
% of Holdings
5.2%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
41,666
Price
$6.28
Total Value
$261.61K
Shares Held After
1,774,781
% of Holdings
2.3%
Travere Therapeutics, Inc. (TVTX)
Coughlin Timothy — Director
Shares
3,250
Price
$43.49
Total Value
$141.34K
Shares Held After
52,250
% of Holdings
5.9%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bunnage Mark E. — EVP, Chief Scientific Officer
Shares
33
Price
$453.45
Total Value
$14.96K
Shares Held After
7,284
% of Holdings
0.5%
Inspire Medical Systems, Inc. (INSP)
Rondoni John — Chief Product and Innovation Officer.
Shares
2,641
Price
$43.28
Total Value
$114.30K
Shares Held After
27,165
% of Holdings
8.9%
Orchestra BioMed Holdings, Inc. (OBIO)
Hochman David P — Director
Shares
5,000
Price
$3.77
Total Value
$18.85K
Shares Held After
1,059,029
% of Holdings
0.5%
Vivani Medical, Inc. (VANI)
Williams Gregg — Director
Shares
1,587,301
Price
$1.26
Total Value
$2.00M
Shares Held After
34,531,785
% of Holdings
4.6%
Orchestra BioMed Holdings, Inc. (OBIO)
Aryeh Jason — Director
Shares
8,971
Price
$3.90
Total Value
$34.99K
Shares Held After
117,453
% of Holdings
7.6%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
5,000
Price
$20.70
Total Value
$103.50K
Shares Held After
43,415
% of Holdings
11.5%
Mirum Pharmaceuticals, Inc. (MIRM)
Ramasastry Saira — Director
Shares
2,000
Price
$109.47
Total Value
$218.94K
Shares Held After
0
% of Holdings
100.0%
MYOMO, INC. (MYO)
KIRK THOMAS F — Director
Shares
31,605
Price
$0.91
Total Value
$28.75K
Shares Held After
585,462
% of Holdings
5.4%
CareDx, Inc. (CDNA)
TORRES ARTHUR A — Director
Shares
6,484
Price
$19.89
Total Value
$128.98K
Shares Held After
38,665
% of Holdings
14.4%
COLLEGIUM PHARMACEUTICAL, INC (COLL)
Freund John Gordon — Director
Shares
4,127
Price
$34.54
Total Value
$142.55K
Shares Held After
83,972
% of Holdings
4.7%
DAVITA INC. (DVA)
HEARTY JAMES O — Chief Compliance Officer
Shares
15,000
Price
$193.98
Total Value
$2.91M
Shares Held After
22,389
% of Holdings
40.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$572.25
Total Value
$183.12K
Shares Held After
40,513
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$571.23
Total Value
$182.79K
Shares Held After
40,833
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
616
Price
$569.94
Total Value
$351.08K
Shares Held After
41,153
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,682
Price
$569.03
Total Value
$957.10K
Shares Held After
41,769
% of Holdings
3.9%
BRUKER CORP (BRKR)
Munch Mark — EXEC VP&PRES BRUKER NANO INC.
Shares
2,000
Price
$43.90
Total Value
$87.80K
Shares Held After
128,443
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,211
Price
$568.07
Total Value
$1.82M
Shares Held After
43,451
% of Holdings
6.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,874
Price
$567.04
Total Value
$1.06M
Shares Held After
46,662
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,477
Price
$566.19
Total Value
$836.26K
Shares Held After
48,536
% of Holdings
3.0%
GILEAD SCIENCES, INC. (GILD)
Mercier Johanna — Chief Comm & Corp Aff Officer
Shares
700
Price
$132.75
Total Value
$92.93K
Shares Held After
125,779
% of Holdings
0.6%
Showing 401–450 of 1863 transactions (page 9 of 38)